Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Indian Journal of Thoracic and Cardiovascular Surgery
Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery 3/2018

19.11.2018 | Review Article

Current role of saphenous vein graft in coronary artery bypass grafting

verfasst von: Sajjad Raza, Carolyn Chang, Salil Vasudeo Deo, Joseph Frank Sabik III

Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery | Sonderheft 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Saphenous vein was the conduit used in the first series of coronary artery bypass grafting (CABG), and, with the exception of surgical revascularization of the left anterior descending artery, it remains the most commonly used bypass conduit. However, its durability and longevity are not ideal. Arterial grafts have better patency than saphenous vein grafts and therefore should be preferred over them. However, in certain situations, like grafting right coronary arteries with lesser degree of proximal stenosis and higher competitive flow, or in certain patient populations, like those at very high risk of wound infections and octogenarians, arterial grafting may not be the best option and saphenous vein grafting should be considered instead.
Literatur
1.
2.
3.
Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012;125:188–97.CrossRefPubMed
4.
Martínez-González B, Reyes-Hernández CG, Quiroga-Garza A, et al. Conduits Used in Coronary Artery Bypass Grafting: A Review of Morphological Studies. Ann Thorac Cardiovasc Surg. 2017;23:55–65.CrossRefPubMedPubMedCentral
5.
Favaloro RG, Effler DB, Groves LK, Sheldon WC, Riahi M. Direct myocardial revascularization with saphenous vein autograft. Clinical experience in 100 cases. Dis Chest. 1969;56:279–83.CrossRefPubMed
6.
Sabik JF 3rd, Lytle BW, Blackstone EH, Houghtaling PL, Cosgrove DM. Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg. 2005;79:544–51.CrossRefPubMed
7.
Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616–26.CrossRefPubMed
8.
Chesebro JH, Fuster V, Elveback LR, et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med. 1984;310:209–14.CrossRefPubMed
9.
Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, Lespérance J. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation. 1985;72:V71–8.PubMed
10.
Campeau L, Lespérance J, Hermann J, Corbara F, Grondin CM, Bourassa MG. Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries. Circulation. 1979;60:1–5.CrossRefPubMed
11.
de Vries MR, Simons KH, Jukema JW, Braun J, Quax PH. Vein graft failure: from pathophysiology to clinical outcomes. Nat Rev Cardiol. 2016;13:451–70.CrossRefPubMed
12.
Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916–31.CrossRefPubMed
13.
Angelini GD, Passani SL, Breckenridge IM, Newby AC. Nature and pressure dependence of damage induced by distension of human saphenous vein coronary artery bypass grafts. Cardiovasc Res. 1987;21:902–7.CrossRefPubMed
14.
Kennedy JH, Lever MJ, Addis BJ, Paneth M. Changes in vein interstitium following distension for aortocoronary bypass. J Cardiovasc Surg (Torino). 1989;30:992–5.
15.
Unni KK, Kottke BA, Titus JL, Frye RL, Wallace RB, Brown AL. Pathologic changes in aortocoronary saphenous vein grafts. Am J Cardiol. 1974;34:526–32.CrossRefPubMed
16.
Bulkley BH, Hutchins GM. Accelerated "atherosclerosis". A morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation. 1977;55:163–9.CrossRefPubMed
17.
Barboriak JJ, Batayias GE, Pintar K, Tieu TM, Van Horn DL, Korns ME. Late lesions in aorta-coronary artery vein grafts. J Thorac Cardiovasc Surg. 1977;73:596–601.PubMed
18.
Kern WH, Dermer GB, Lindesmith GG. The intimal proliferation in aortic-coronary saphenous vein grafts. Light and electron microscopic studies. Am Heart J. 1972;84:771–7.CrossRefPubMed
19.
Fuster V, Dewanjee MK, Kaye MP, Josa M, Metke MP, Chesebro JH. Noninvasive radioisotopic technique for detection of platelet deposition in coronary artery bypass grafts in dogs and its reduction with platelet inhibitors. Circulation. 1979;60:1508–12.CrossRefPubMed
20.
Chesebro JH, Clements IP, Fuster V, et al. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med. 1982;307:73–8.CrossRefPubMed
21.
Griffith LS, Bulkley BH, Hutchins GM, Brawley RK. Occlusive changes at the coronary artery--bypass graft anastomosis. Morphologic study of 95 grafts. J Thorac Cardiovasc Surg. 1977;73:668–79.PubMed
22.
Yanagawa B, Algarni KD, Singh SK, et al. Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure. J Thorac Cardiovasc Surg. 2014;148:515–520.e2.CrossRefPubMed
23.
McLean RC, Nazarian SM, Gluckman TJ, et al. Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery. J Cardiovasc Surg (Torino). 2011;52:877–85.
24.
Ahmed JM, Dangas G, Lansky AJ, et al. Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting. Am J Cardiol. 2001;87:401–5.CrossRefPubMed
25.
Raza S, Blackstone EH, Houghtaling PL, et al. Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency. J Am Coll Cardiol. 2017;70:515–24.CrossRefPubMed
26.
27.
Raza S, Sabik JF 3rd, Ainkaran P, Blackstone EH. Coronary artery bypass grafting in diabetics: A growing health care cost crisis. J Thorac Cardiovasc Surg. 2015;150:304–2.CrossRefPubMedPubMedCentral
28.
Roth JA, Cukingnan RA, Brown BG, Gocka E, Carey JS. Factors influencing patency of saphenous vein grafts. Ann Thorac Surg. 1979;28:176–83.CrossRefPubMed
29.
Zenati MA, Shroyer AL, Collins JF, et al. Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On/Off Bypass) Trial. J Thorac Cardiovasc Surg. 2011;141:338–44.CrossRefPubMed
30.
Hess CN, Lopes RD, Gibson CM, et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation. 2014;130:1445–51.CrossRefPubMedPubMedCentral
31.
Zenati MA, Gaziano JM, Collins JF, et al. Choice of vein-harvest technique for coronary artery bypass grafting: rationale and design of the REGROUP trial. Clin Cardiol. 2014;37:325–30.CrossRefPubMedPubMedCentral
32.
Kopjar T, Dashwood MR. Endoscopic Versus "No-Touch" Saphenous Vein Harvesting for Coronary Artery Bypass Grafting: A Trade-Off Between Wound Healing and Graft Patency. Angiology. 2016;67-121-32.
33.
Samano N, Geijer H, Liden M, Fremes S, Bodin L, Souza D. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: A randomized trial. J Thorac Cardiovasc Surg. 2015;150:880–8.CrossRefPubMed
34.
Winkler B, Reineke D, Heinisch PP, et al. Graft preservation solutions in cardiovascular surgery. Interact Cardiovasc Thorac Surg. 2016;23:300–9.CrossRefPubMed
35.
Harskamp RE, Alexander JH, Schulte PJ, et al. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. JAMA Surg. 2014;149:798–805.CrossRefPubMedPubMedCentral
36.
Taggart DP, Ben Gal Y, Lees B, et al. A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting. Ann Thorac Surg. 2015;99:2039–45.CrossRefPubMed
37.
Deo SV, Dunlay SM, Shah IK, et al. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis. J Card Surg. 2013;28:109–16.CrossRefPubMed
38.
Belch JJ, Dormandy J, Biasi GM, et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010;52:825–33.CrossRefPubMed
39.
Brilakis ES, Held C, Meier B, et al. Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial. Am Heart J. 2013;166:474–80.CrossRefPubMed
40.
Knatterud GL, Rosenberg Y, Campeau L, et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation. 2000;102:157–65.PubMed
41.
Sabik JF 3rd, Lytle BW, Blackstone EH, Khan M, Houghtaling PL, Cosgrove DM. Does competitive flow reduce internal thoracic artery graft patency? Ann Thorac Surg. 2003;76:1490–6.CrossRefPubMed
42.
Di Mauro M, Contini M, Iacò AL, et al. Bilateral internal thoracic artery on the left side: a propensity score-matched study of impact of the third conduit on the right side. J Thorac Cardiovasc Surg. 2009;137:869–74.CrossRefPubMed
43.
Maniar HS, Sundt TM, Barner HB, et al. Effect of target stenosis and location on radial artery graft patency. J Thorac Cardiovasc Surg. 2002;123:45–52.CrossRefPubMed
44.
Raza S, Sabik JF 3rd, Masabni K, Ainkaran P, Lytle BW, Blackstone EH. Surgical revascularization techniques that minimize surgical risk and maximize late survival after coronary artery bypass grafting in patients with diabetes mellitus. J Thorac Cardiovasc Surg. 2014;148:1257–64.CrossRefPubMed
Metadaten
Titel
Current role of saphenous vein graft in coronary artery bypass grafting
verfasst von
Sajjad Raza
Carolyn Chang
Salil Vasudeo Deo
Joseph Frank Sabik III
Publikationsdatum
19.11.2018
Verlag
Springer Singapore
Erschienen in
Indian Journal of Thoracic and Cardiovascular Surgery / Ausgabe Sonderheft 3/2018
Print ISSN: 0970-9134
Elektronische ISSN: 0973-7723
DOI
https://doi.org/10.1007/s12055-018-0759-3

Weitere Artikel der Sonderheft 3/2018

Indian Journal of Thoracic and Cardiovascular Surgery 3/2018 Zur Ausgabe

Review Article

Myocardial revascularization: the evolution of the STS database and quality measurement for improvement

Review Article

Bilateral internal thoracic artery use in coronary bypass surgery: is there a benefit?

Review Article

Viability testing to guide myocardial revascularisation in patients with heart failure

Review Article

CABG in patients with left ventricular dysfunction: indications, techniques and outcomes

Review Article

The effect of storage solutions on endothelial function and saphenous vein graft patency

Review Article

The role of stem cells in treating coronary artery disease in 2018

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.